Assistance Publique - Hôpitaux de Paris: Cystic Fibrosis trials
The registry lists 30 Cystic Fibrosis studies with Assistance Publique - Hôpitaux de Paris as lead sponsor. 2 are open to participants now and 0 have results posted.
Phase 2 2Phase 3 2Phase 4 2No phase 25(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Oral Health Status of Cystic Fibrosis Patients. An Online Survey in Collaboration With the Vaincre la Mucoviscidose Patient Association.RecruitingNCT06356246
- Development of Non-Invasive Prenatal Diagnosis for Single Gene DisordersRecruitingNCT06147414
- Volatilomic Approaches for the Study of CFTR Modulators (VOLATIL-CF)CompletedNCT05726994
- Cystic Fibrosis Blood NeutrophilsCompletedNCT04970225Not applicable
- Concerns of Children Whose Parents Have Cystic FibrosisCompletedNCT04702386
- Comparison Between Ultra-low-dose Computed Tomography and Lung MRI in Cystic FibrosisCompletedNCT04644471Not applicable
- Parenting Concerns in Patients With Cystic Fibrosis (MucoPar)CompletedNCT04133246Not applicable
- Modeling of Chest Physiotherapy Using Impedance Measurements (PHYSIOMOD)CompletedNCT04094441Not applicable
- Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.CompletedNCT03894657Not applicable
- Impact of the Introduction of ORKAMBI on Anxiety, Depression, Quality of Life and Adherence of Adolescents and Young AdultsCompletedNCT03659214
- Study of Circulating Blood Cell Monocytes as Predictive Biomarker of Bone Cystic Fibrosis Disease. Impact of CFTR Correctors.CompletedNCT03492567Not applicable
- Real-life Follow-up of Cystic Fibrosis Patients Treated With Ivacaftor+Lumacaftor (Orkambi*)CompletedNCT03475381
- Prevalence and Impact of Depression and Anxiety in Cystic FibrosisCompletedNCT03424486
- Prospective Study of the Phenotypic Expression of Cystic Fibrosis (CF) Screened Positive Newborns With an Atypical Form of CF (DPAM)CompletedNCT02869932Not applicable
- 6 Minute Walk Test in Cystic FibrosisCompletedNCT02538575Not applicable
- Cystic Fibrosis Diagnosis by Analyzing Nasal BrushingStatus unknownNCT02433132Not applicable
- Comparison of Non-invasive Measurement Methods of Hepatic Fibrosis in Cystic FibrosisCompletedNCT02342964Not applicable
- Evaluation of the Lung Clearance IndexCompletedNCT02342951Not applicable
- Effect of Miglustat on the Nasal Potential Difference in Patients With Cystic Fibrosis Homozygous for the F508del MutationCompletedNCT02325362Phase 2/3
- Development of a New Tool for Dyspnea Measurement in Chronic Respiratory DiseasesCompletedNCT02229994
- Ivacaftor in French Patients With Cystic Fibrosis and a G551D MutationCompletedNCT02194881
- Impact of Global Care of the Pain at Chronic Painful Patients Affected by Cystic FibrosisCompletedNCT01915875Not applicable
- Extrapulmonary Effects of Cystic Fibrosis on Physical Activity of Adult Patients.CompletedNCT01848392
- Oxygen Therapy in Cystic FibrosisTerminatedNCT01586728Not applicable
- Cohort Study Evaluating the Clinical Effectiveness, Safety and Immunogenicity to the Pandemic Influenza VaccinationCompletedNCT01499914Phase 4
- Osteopathic Treatment in Adult Patients With Cystic FibrosisCompletedNCT01293019Phase 3
- Non Invasive Study of the Hepatic Fibrosis in Paediatrics by the Method of Study of Pediatric Hepatic FibrosisCompletedNCT01072721Not applicable
- Sleep in Patients With Cystic FibrosisCompletedNCT00804661
- Interest of Gentamicin-induced Readthrough in Cystic Fibrosis PatientsTerminatedNCT00376428Phase 2
- Cystic Fibrosis and Totally Implantable Vascular Access DevicesCompletedNCT00244270Phase 4